Search - tctmd.com

Displaying 181 - 200 of 390

Sort: Relevancy | Date

News Industry News

SentreHEART Receives CE Mark for LARIAT-RS™ 50mm and Expanded Indication for Left Atrial Appendage Exclusion

May 03, 2019

News Industry News

First-of-its-Kind Large Access Dilator Launches in U.S., Following Cleveland Clinic Case

May 02, 2019

Presentation Fellows 2019

LAA Closure, PFO Closure, and Other Novel Structural Heart Procedures

Presenter: Michael Lim

April 14, 2019

Presentation ARCH 2019

LAA Closure Patient Selection, Imaging and Anti-Thrombotic Therapy

Presenter: Steven J Yakubov

April 11, 2019

Presentation CIT 2019

Pre-Procedural and Procedural Imaging for LAA Closure

Presenter: Jacqueline Saw

March 28, 2019

Presentation JIM 2019

Left Atrial Appendage Closure complications

Presenter: Francesco Bedogni

February 14, 2019

Presentation Controversies and Advances 2018

LAA Closure: A First Line Option

Presenter: Brian Whisenant

November 16, 2018

Presentation Controversies and Advances 2018

Debate: LAA Closure - Should This Be First Line Therapy

Presenter: David R. Holmes

November 16, 2018

Presentation Cardiovascular Interventions 2018

Left Atrial Appendage Closure

Presenter: Matthew J. Price

October 26, 2018

News Daily News

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

Caitlin E. Cox

October 04, 2018

Presentation TCT 2018

LAA Closure: Challenging Case Vignettes

Presenter: Saibal Kar, Horst Sievert, Philippe Garot, Jan Kovac, Ashish Pershad, Ramon Quesada, Peter B. Sick, Brian K. Whisenant

September 24, 2018

Presentation TCT 2018

Epicardial LAA closure: From Surgical Results to Transpericardial Applications

Presenter: Saibal Kar, Horst Sievert, Krzysztof Bartus

September 24, 2018

Presentation TCT 2018

The Watch TAVR Trial: Rationale, Design and Status

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Samir R. Kapadia

September 24, 2018

Presentation TCT 2018

The WaveCrest Device and US Pivotal Trial

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Gregg W. Stone

September 24, 2018

Presentation TCT 2018

The Amulet Platform, Experience and US Pivotal Trial

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Apostolos Tzikas

September 24, 2018

Presentation TCT 2018

The Watchman Platform, ASAP Too and Flex: Rationale, Device and Overview of the Trials

Presenter: Vivek Y. Reddy, Brian K. Whisenant

September 24, 2018

Presentation TCT 2018

FDA Perspectives on New Devices and Indications for LAA Closure

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Andrew Farb

September 24, 2018

Presentation TCT 2018

The LAAO Registry: Overview, Data Adjudication, and Emerging Insights

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Paul D. Varosy

September 24, 2018

Presentation TCT 2018

Managing a Busy LAA Closure Program: Patient Selection, Education, Consent, Screening, and Periprocedural Care

Presenter: James B. Hermiller Jr, David Hildick-Smith, George S. Hanzel

September 24, 2018

Presentation TCT 2018

Adjunctive Pharmacology Following LAA Closure in Anticoagulant Indicated and Contraindicated Patients

Presenter: James B. Hermiller Jr, David Hildick-Smith, Martin W. Bergmann

September 24, 2018

Advertisement

SentreHEART Receives CE Mark for LARIAT-RS™ 50mm and Expanded Indication for Left Atrial Appendage Exclusion

First-of-its-Kind Large Access Dilator Launches in U.S., Following Cleveland Clinic Case

LAA Closure, PFO Closure, and Other Novel Structural Heart Procedures

LAA Closure Patient Selection, Imaging and Anti-Thrombotic Therapy

Pre-Procedural and Procedural Imaging for LAA Closure

Left Atrial Appendage Closure complications

LAA Closure: A First Line Option

Debate: LAA Closure - Should This Be First Line Therapy

Left Atrial Appendage Closure

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

LAA Closure: Challenging Case Vignettes

Epicardial LAA closure: From Surgical Results to Transpericardial Applications

The Watch TAVR Trial: Rationale, Design and Status

The WaveCrest Device and US Pivotal Trial

The Amulet Platform, Experience and US Pivotal Trial

The Watchman Platform, ASAP Too and Flex: Rationale, Device and Overview of the Trials

FDA Perspectives on New Devices and Indications for LAA Closure

The LAAO Registry: Overview, Data Adjudication, and Emerging Insights

Managing a Busy LAA Closure Program: Patient Selection, Education, Consent, Screening, and Periprocedural Care

Adjunctive Pharmacology Following LAA Closure in Anticoagulant Indicated and Contraindicated Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content